Lotus Pharm vs G&E Herbal Biotechnology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and G&E Herbal Biotechnology (4911) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ G&E Herbal Biotechnology

0%+226%-61%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYG&E Herbal BiotechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$11.6 million-50.7%
Sep 2026NT$2.77 billion+128.0%NT$11.4 million-56.0%
Aug 2026NT$2.11 billion+81.7%NT$11.6 million-55.3%
Jul 2026NT$2.49 billion+3.9%NT$11.3 million-59.5%
Jun 2026NT$3.4 billion+225.5%NT$11.6 million-57.6%
May 2026NT$2.32 billion+105.8%NT$11.6 million-56.9%
Apr 2026NT$3.09 billion+19.9%NT$11.3 million-56.4%
Mar 2026NT$4.35 billion+173.6%NT$10.6 million-59.8%
Feb 2026NT$2.24 billion+131.5%NT$10.8 million-58.7%
Jan 2026NT$2.05 billion-5.5%NT$10.7 million-60.9%
Dec 2025NT$2.44 billion+66.9%NT$22.8 million-6.5%
Nov 2025NT$1.06 billion-0.2%NT$22.8 million-4.3%
Oct 2025NT$2.75 billion+46.0%NT$23.6 million-0.2%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16